Our science
Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.
We want to change the way iron deficiency anemia is treated, and chemotherapy-induced myelosuppression is prevented.
Read about our intravenous iron.
Read about our intravenous CDK 4/6 inhibitor for Extensive-Stage Small Cell Lung Cancer therapeutic space.
A leader in providing innovative treatments for unmet patient needs, with a focus on iron metabolism and blood related disorders.